← Back to Search

Exercise During Chemotherapy for Breast Cancer

N/A

Waitlist Available

Led By Meghan Karuturi

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline up to 1 month after chemotherapy

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing if it's feasible for older women with breast cancer to exercise during chemotherapy. Researchers hope this will help reduce the chemotherapy-toxicity risk.

Who is the study for?

This trial is for women aged 65 or older with Stage I-III breast cancer, about to start chemotherapy. They must be able to walk, do moderate exercise, and commit to the study's requirements. Women with serious medical conditions that prevent them from exercising cannot participate.

What is being tested?

The trial tests if it's practical for older women receiving chemotherapy for breast cancer to follow an exercise program. It includes questionnaires, discussions, using a medical device, quality-of-life assessments, and educational interventions about physical activity.

What are the potential side effects?

Since this trial focuses on the feasibility of exercise during treatment rather than medication side effects, specific side effects are not listed. However, participants may experience general fatigue or discomfort associated with increased physical activity.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 month after chemotherapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 month after chemotherapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month after chemotherapy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adherence

Compliance

Retention

Secondary study objectives

Geriatric assessment

Incidence of adverse events (AEs)

Outcome Expectations for Exercise (OEE) Scale Questionnaires

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (coaching, exercise, questionnaire)Experimental Treatment6 Interventions

Patients participate in one-on-one coaching sessions with a health coach QW to discuss the content offered in the program, and challenges they are currently facing in achieving their exercise goals. Patients receive a copy of the WWE workbook, wear a fitness tracker and are encouraged to achieve 150 minutes of walking per week during chemotherapy and up to 1 month after chemotherapy. Patients also participate in the Growing Stronger Strength Training Program and receive instruction manuals. They perform the initial 2 exercises 2 days per week for 4 weeks, and subsequent 2 exercises 2 days per week for the remainder of the chemotherapy course. Patients maintain exercise logs and complete questionnaires over 30-45 minutes at baseline, end of chemotherapy and at 1 month after chemotherapy.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Discussion

2021

N/A

~180

Do I qualify?Apply below to find out